DUSP2 and prostate carcinoma: DUSP2 is an important regulator of immune responses, and its low expression has been detected in various tumors, such as prostate cancer, glioma, and leukemia (Hartmann et al., 2016; Dan et al., 2020; Haag et al., 2016).